Baxter International Inc (BAX)
29.20
-0.10
(-0.34%)
USD |
NYSE |
Dec 27, 16:00
29.21
+0.01
(+0.03%)
After-Hours: 20:00
Baxter International Research and Development Expense (Annual): 667.00M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Boston Scientific Corp | 1.414B |
| Haemonetics Corp | 54.44M |
| Becton Dickinson & Co | 1.19B |
| LeMaitre Vascular Inc | 16.97M |
| Globus Medical Inc | 124.01M |